These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 5588744

  • 1. [Stimulation of the beta-cytotropic effect of tolbutamide by secretin in man].
    Bottermann P, Souvatzoglou A, Schwarz K.
    Klin Wochenschr; 1967 May 15; 45(10):549-50. PubMed ID: 5588744
    [No Abstract] [Full Text] [Related]

  • 2. Insulin response to glucose, tolbutamide, secretin, and isoprenaline in maturity-onset diabetes mellitus.
    Deckert T, Lauridsen UB, Madsen SN, Mogensen P.
    Dan Med Bull; 1972 Oct 15; 19(7):222-6. PubMed ID: 5079926
    [No Abstract] [Full Text] [Related]

  • 3. Selective loss of beta cell response to glucose in chronic pancreatitis.
    Kalk WJ, Vinik AI, Bank S, Keller P, Jackson WP.
    Horm Metab Res; 1974 Mar 15; 6(2):95-8. PubMed ID: 4597425
    [No Abstract] [Full Text] [Related]

  • 4. Dynamics of insulin secretion in vitro: effects of repeated induction of insulin release by single and multiple stimulants.
    Telib M, Pfeiffer EF.
    Endokrinologie; 1970 Mar 15; 56(2):189-95. PubMed ID: 5488423
    [No Abstract] [Full Text] [Related]

  • 5. Effect of enteric hormones on insulin secretion.
    Kahil ME, McIlhaney GR, Jordan PH.
    Metabolism; 1970 Jan 15; 19(1):50-7. PubMed ID: 5410662
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Characterisation of the effect of intravenous infusion of glucose and tolbutamide on the insulin delivery rate in man.
    Asano T, Sasaki H, Okumura M.
    Diabetologia; 1978 Sep 15; 15(3):159-64. PubMed ID: 700280
    [Abstract] [Full Text] [Related]

  • 8. Insulin and glucagon release from isolated islets of Langerhans. Effect of enteric factors.
    Buchanan KD, Vance JE, Williams RH.
    Diabetes; 1969 Jun 15; 18(6):381-6. PubMed ID: 4892443
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Enchancement of reactive insulin secretion in vitro by cobalt-chloride (CoC1 2 ).
    Telib M, Pfeiffer EF.
    Horm Metab Res; 1969 Jan 15; 1(1):44. PubMed ID: 5407068
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Insulin stimulation by secretin in diabetics. Effects of repeated and of varied doses.
    Hindberg I, Enk B, Persson I.
    Horm Metab Res; 1970 May 15; 2(3):131-4. PubMed ID: 5535406
    [No Abstract] [Full Text] [Related]

  • 14. [Comparative use of gliquidone and tolbutamide administered intravenously].
    Zilker T, Lüders L, Bottermann P.
    MMW Munch Med Wochenschr; 1975 Sep 05; 117(36):1421-2. PubMed ID: 126376
    [No Abstract] [Full Text] [Related]

  • 15. Effect of long-term tolbutamide treatment on glucose tolerance and insulin secretion in maturity-onset diabetes without obesity.
    Lauvaux JP, Mandart G, Heymans G, Ooms HA.
    Horm Metab Res; 1972 Mar 05; 4(2):58-62. PubMed ID: 5028221
    [No Abstract] [Full Text] [Related]

  • 16. Insulin response to glucose and tolbutamide in "essential" versus "pancreatic" mild glucose intolerance.
    Vague P, Ramahandridona G, Gerolami A.
    Diabetes; 1974 Nov 05; 23(11):896-901. PubMed ID: 4430416
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The effect of secretin on glucose-stimulated insulin secretion in man.
    Shima K, Tarui S.
    Endocrinol Jpn; 1974 Feb 05; 21(1):13-8. PubMed ID: 4426303
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.